Z-1825-2012 Class II Terminated
FDA device recall Z-1825-2012 was initiated by App Pharmaceuticals Llc on May 20, 2010 and is designated Class II. Reason for recall: CGMP Deviations: Incomplete documentation associated with test results. The recall status is terminated (terminated Jun 20, 2012). Affected quantity: Product Code 504501 (1 mL): 454,275 vials; Product Code 504505 (5 mL): 119,325 vials.
Recall details
- Product Type
- Devices
- Report Date
- Jun 27, 2012
- Initiation Date
- May 20, 2010
- Termination Date
- Jun 20, 2012
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- Product Code 504501 (1 mL): 454,275 vials; Product Code 504505 (5 mL): 119,325 vials
Product description
Reason for recall
Distribution pattern
Nationwide Distribution and Puerto Rico
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1825-2012
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for App Pharmaceuticals Llc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.